InsidersTradesSigma
Explore the complete record of transactions filed by Hidenobu Ishizaki, Shareholder. Officer active across 1 companies, notably ノイルイミューン・バイオテック株式会社. Aggregated, 1 disclosures have been logged. The latest transaction was disclosed on 5 July 2023 — Holding update. Regulator: EDINET (Japan FSA). All data is accessible without signup.
1 of 1 declaration
Hidenobu Ishizaki is a major shareholder of Noil Immune Biotech Co., Ltd. As a shareholder, he influences the strategic direction and governance decisions of the company. Hidenobu Ishizaki is involved in the biotechnology sector, contributing to innovation and research. His commitment to operational excellence is essential for the success of his investments.